Advances in Iron Chelation Therapy: Towards A New Oral Formulation
Advances in Iron Chelation Therapy: Towards A New Oral Formulation

Farid Ghazizadeh; Mehran Noroozi; Lachin Seifi

Volume 10, Issue 7 , July 2022, , Pages 16387-16395

https://doi.org/10.22038/ijp.2022.65351.4929

Abstract
  Background: Patients with thalassemia major require regular monthly blood transfusion and excess iron from multiple blood transfusion deposits in different organs of the body, causing ...  Read More
Comparison of Quality of Life in Thalassemia Major Patients with Injectable and oral Iron Depletion
Comparison of Quality of Life in Thalassemia Major Patients with Injectable and oral Iron Depletion

Majid Naderi; Ghasem Miri-Aliabad; Gholamreza Soleimani; Seyed Hosein Soleimanzadeh Mousavi; Saeideh Yaghoubi

Volume 9, Issue 11 , November 2021, , Pages 14747-14755

https://doi.org/10.22038/ijp.2021.54193.4285

Abstract
  Background: One of the factors reducing the satisfaction and quality of life in thalassemia is the injection of iron-depleting drugs that always cause complications in these people. ...  Read More
Prevalence of Restless Legs Syndrome (RLS) in children with thalassemia major in Ali Asghar Hospital in Zahedan, Iran
Prevalence of Restless Legs Syndrome (RLS) in children with thalassemia major in Ali Asghar Hospital in Zahedan, Iran

Majid Naderi; Zahra Ghiasi; Alireza Khosravi; Seyed hosein Soleimanzadeh Mousavi; Saeideh Yaghoubi

Volume 9, Issue 8 , August 2021, , Pages 14097-14104

https://doi.org/10.22038/ijp.2020.52325.4159

Abstract
  Introduction: Thalassemia major is one of the most debilitating chronic and inherited diseases caused by impaired hemoglobin production. To improve the quality of life in the long-term ...  Read More
The Comparison of Desfonak with Desferal in Patients with Beta Thalassemia Major: A Randomized Crossover Clinical Trial
The Comparison of Desfonak with Desferal in Patients with Beta Thalassemia Major: A Randomized Crossover Clinical Trial

Mohammad Reza Golpayegani; Nargece Soraya; Reza Akramipour; Mansour Rezaei

Volume 7, Issue 10 , October 2019, , Pages 10195-10204

https://doi.org/10.22038/ijp.2019.41060.3459

Abstract
  Background Beta thalassemia (β-thalassemia) is one of the most common genetic disorders that reduces the amount of specific chain production in hemoglobin. The aim of this study ...  Read More
Health-Related Quality of Life in Iranian Patients with Thalassemia Major: A Systematic Review and Meta-Analysis
Health-Related Quality of Life in Iranian Patients with Thalassemia Major: A Systematic Review and Meta-Analysis

Mitra Goli; Shahin Salarvand; Fazel Dehvan; Houshyar Ghafouri; Sahar Dalvand; Reza Ghanei Gheshlagh; Amir Vahedian-azimi

Volume 6, Issue 11 , November 2018, , Pages 8483-8494

https://doi.org/10.22038/ijp.2018.32565.2869

Abstract
  Background: Thalassemia is the most common genetic disorder in Iran. High treatment costs, the use of iron chelators, comorbidities and periodic visits affect the quality of life in ...  Read More
A Comparison of Quality of Life between Adolescences with Beta Thalassemia Major and their Healthy Peers
A Comparison of Quality of Life between Adolescences with Beta Thalassemia Major and their Healthy Peers

Shahram Baraz; Mojtaba Miladinia; Elham Mosavinouri

Volume 4, Issue 1 , January 2016, , Pages 1195-1204

https://doi.org/10.22038/ijp.2016.6228

Abstract
  Background The chronic genetic blood disorder, thalassemia, affects Quality of life (QOL) negatively. Regarding this, if adolescences with thalassemia are treated well, they will grow ...  Read More
Spurious Hyperleukocytosis
Spurious Hyperleukocytosis

Amitabh singh; Anirban Mandal; Bhavika Rishi; Puneet Sahi

Volume 3, Issue 4.2 , August 2015, , Pages 799-800

https://doi.org/10.22038/ijp.2015.4512

Abstract
  Hyperleukocytosis is an oncological emergency but is extremely rare in non-malignant conditions. Nucleated RBCs give rise to spuriously high total leucocyte count and cause clinical ...  Read More